language_icon
EN
HI

Valiant Laboratories Share price

VALIANTLAB

76.54

1.50 (2.00%)
NSE
BSE
Last updated on 20 May, 2026 | 15:30 IST
Today's High

76.90

Today's Low

74.05

52 Week Low

49.51

52 Week High

115.19

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Valiant Laboratories Chart

Valiant Laboratories Share Key Metrics

Volume
16310.00
Market Cap
415.71 CR
LTQ@LTP
50@76.54
ATP
75.69
Var Margin
100 %
Circuit Range
71.29-78.79
Delivery %
0 %
Value
12.35 L
ASM/GSM
No
Market Lot
1

Summary

20 May, 2026 | 15:30 को, Valiant Laboratories का शेयर प्राइस आज ₹76.54 पर है, जो दिन के लिए 1.50% की 2.00 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹74.05 और ₹76.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹49.51 से ₹115.19 तक रही है। ट्रेडिंग गतिविधि के मामले में, Valiant Laboratories ने 16310 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹54312500 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹7569 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 50,7654 रही। यह स्टॉक ₹71.29-78.79 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹12.35 L है। दिन के लिए डिलीवरी परसेंटेज % रही। इसके अतिरिक्त, Valiant Laboratories वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Valiant Laboratories Fundamentals

View More
P/E Ratio

0

P/B Ratio

1.31

Div. Yield

0

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Valiant Laboratories Resistance and Support

Pivot 75

Resistance

First Resistance

77

Second Resistance

78.95

Third Resistance

80.95

Support

First Support

73.05

Second Support

71.05

Third Support

69.1

Valiant Laboratories Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

74.94%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.2%

Domestic Institutional Investors

0%

Retail

24.86%

Others

0%

Total Promoters
MAR '26
74.94%

Valiant Laboratories Corporate Actions

DateAgenda
2026-05-14Audited Results

Valiant Laboratories News

Valiant Laboratories Ltd - 543998 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

Valiant Organics Limited, a promoter group entity of Valiant Laboratories, announced the acquisition of 1.86 crore equity shares, representing a 34.26% stake, from Dhanvallabh Ventures LLP through an off-market transaction. This move is part of a larger internal restructuring exercise.
May 20 2026 10:05:00

Valiant Laboratories Limited

Valiant Laboratories Limited announced a proposed inter-se transfer of 18.6 million equity shares (34.26% of total capital) between promoter entities Dhanvallabh Ventures LLP and Valiant Organics Limited. This internal transfer is part of a restructuring exercise by the promoter group.
May 19 2026 23:05:00

Valiant Laboratories Ltd - 543998 - Intimation Recieved Under Regulation 10(5) Of SEBI (SAST) Regulations, 2011

Valiant Laboratories' promoter Dhanvallabh Ventures LLP is set to transfer 1.86 crore equity shares (34.26% stake) to fellow promoter entity Valiant Organics Limited. This inter-se transfer is part of a restructuring exercise by Valiant Organics Limited.
May 19 2026 23:05:00

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Valiant Laboratories' Board has given in-principle approval to explore potential restructuring options across the company, its holding, subsidiaries, and associates. This aims to achieve operational, organizational, and strategic synergies, including possible mergers or demergers.
May 16 2026 18:05:00

Valiant Laboratories Limited

Valiant Laboratories' board approved exploring potential restructuring options across its company, holding, subsidiaries, and associates. The initiative aims to achieve operational, organizational, and strategic synergies, ultimately unlocking long-term shareholder value.
May 16 2026 18:05:00

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Valiant Laboratories received a Monitoring Agency Report for Q4 FY26 confirming appropriate utilization of Rs.81.47 crore rights issue proceeds. The report noted no deviations from the stated objects, with funds largely deployed as per the offer document.
May 14 2026 20:05:00

Valiant Laboratories Limited

Valiant Laboratories received a Monitoring Agency Report for Q4 FY26, confirming that the funds raised through its Rights Issue (INR 81.46 Cr) were utilized appropriately for the stated objects, with no deviations observed. This indicates adherence to the offer document and good governance.
May 14 2026 20:05:00

Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31, 2026.

Valiant Laboratories' board approved FY26 audited results. Standalone revenue grew 62.75% YoY to ₹217.04 crore, turning a net loss of ₹2.15 crore in FY25 into a net profit of ₹5.55 crore. Consolidated revenue rose 78.03% to ₹237.47 crore, but cons. net loss widened to ₹3.27 crore from ₹2.20 crore in FY25.
May 14 2026 19:05:00

Valiant Laboratories Limited

Valiant Laboratories announced the resignation of Mr. Bhanudas D. Patil, Q.C Manager and Senior Management Personnel, citing personal commitments. He will be relieved from services effective April 22, 2026.
Apr 23 2026 14:04:00

Valiant Laboratories Limited

Valiant Laboratories announced the resignation of Mr. Bhanudas D. Patil, Q.C Manager and Senior Management Personnel, citing personal commitments. He will be relieved from services effective April 22, 2026.
Apr 23 2026 14:04:00
Read More

About Valiant Laboratories AboutThe

NSE : 19220  
BSE : 543998  
ISIN : INE0JWS01017  

The Company was originally formed as a partnership firm under Indian Partnership Act 1932 under the name and style of “M/s Bharat Chemicals” pursuant to the deed of partnership dated October 17 1980. Subsequently the partnership firm M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name “Valiant Laboratories Limited” pursuant to certificate of incorporation dated August 16 2021 issued by Central Registration Centre Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area Palghar Maharashtra on leasehold basis admeasuring about 1000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28 L-28 (part) L-29 and L-13 at Tarapur Industrial Area Palghar Maharashtra collectively admeasuring about 3000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1000 million2022- The annual revenue from operations crossed Rs.2000 million- Formed the wholly owned subsidiary VASPL to diversify the business activities

Read More

Valiant Laboratories Management

NamePosition
Mulesh M SavlaNon Executive Independent Director
Santosh S VoraManaging Director
View More

Valiant Laboratories FAQs

Valiant Laboratories शेयर का खरीद मूल्य 76.54 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Valiant Laboratories शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Valiant Laboratories शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Valiant Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.31 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Valiant Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Valiant Laboratories का मार्केट कैप 415.71 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Valiant Laboratories शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 115.19 और 49.51 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost